PDUFA Negotiations End With Differences To Resolve In Commitment Letter
This article was originally published in The Tan Sheet
Executive Summary
The entire PDUFDA VI reauthorization process likely is more than a year from completion, but agreeing on a draft commitment letter is a major milestone for FDA and the pharma industry. It will serve as the foundation of the legislative phase expected to begin in early 2017.